Nebius stock jumps nearly 10% in regular trading as AI-cloud names catch a bid

Nebius stock jumps nearly 10% in regular trading as AI-cloud names catch a bid

New York, Jan 12, 2026, 15:05 ET — Regular session

  • Nebius Group N.V. shares climbed roughly 10% on Monday, pushing further on a tech-driven rally.
  • Traders zeroed in on Nebius’ plan to roll out NVIDIA’s next-gen Rubin platform in 2026.
  • Investors await new capacity and product updates, with a technical webinar scheduled for Jan. 29.

Nebius Group N.V. shares surged close to 10% Monday afternoon, riding the tailwind from a tech sector rally as investors shifted focus back to AI infrastructure names.

This shift is significant since Nebius remains a modest public player in the market for premium graphics chips and data centers—the backbone supporting chatbots and various AI applications. When tech risk appetite rises, stocks like Nebius can experience sharp swings.

It comes as investors scramble to figure out who will snag early access to NVIDIA’s upcoming AI hardware—and who can actually convert that edge into paying clients. That uncertainty has loomed over the “AI cloud” trade since late 2025.

Nebius shares climbed 9.8% to $107.55 in afternoon trading. The stock hit a high of $107.98 and dipped to $96.32 earlier, after closing at $97.93 on Friday, according to market data.

On Jan. 5, the company announced plans to roll out NVIDIA’s Rubin accelerated computing platform via its Nebius AI Cloud and Token Factory product starting in the second half of 2026. Token Factory focuses on “inference,” meaning it runs trained AI models to generate outputs, according to the company. Nebius

Arkady Volozh, founder and CEO, said Nebius plans to be “one of the first on the market” to offer NVIDIA’s Vera Rubin GPUs. The company is targeting customers looking to build “agentic” AI — systems that can plan and act with minimal human input. Businesswire

Tech stocks edged slightly higher. Nvidia rose roughly 1.0%, the Invesco QQQ Trust, tracking the Nasdaq-100, added about 0.3%, and the SPDR S&P 500 ETF climbed close to 0.2%.

NVIDIA confirmed that Rubin is now in full production, with Rubin-based products set to hit partner platforms in the second half of 2026. The company named Nebius as one of the early cloud partners planning to roll out Rubin-based instances next year, alongside bigger players and AI-focused competitors like CoreWeave. Nvidia

Investors are zeroing in on near-term capacity signals—the less flashy side that often drives results. Nebius plans a technical webinar on its Nebius AI Cloud 3.1 update, with a live Q&A, set for Jan. 29. Nebius

The road ahead isn’t smooth. Rubin won’t be available for months, and even before new hardware hits the market, the stock’s been swinging wildly day to day. High short interest could push it either way. MarketBeat data shows 33.1 million Nebius shares were sold short as of Dec. 15, roughly 13% of the public float. Marketbeat

Traders are zeroing in on the Jan. 29 webinar, expecting concrete updates on capacity, customer uptake, and timelines — details that could either cement the recent rally or trigger a pullback.

Stock Market Today

  • AI to shape markets in 2026 as investors seek tangible returns
    January 12, 2026, 3:49 PM EST. AI in 2026 moves from hype to profitability as firms seek returns on AI bets. Goldman Sachs cites more than $500 billion in AI-related investment planned for 2026. Investors eye tangible business models and longer-term value, with 93% of AI investors planning to stay exposed per Motley Fool's outlook; some will add, others maintain. The focus broadens beyond top S&P names toward foundational AI enablers: data-center builders, network components, and power and cooling providers. EMCOR Group (EME) embodies the trend: Q3 revenue and earnings hit records, RPOs rose 29% to $12.6 billion, a dividend raised to $0.40, and a $500 million expansion of the buyback. A broader data-center cycle could sustain an AI-led market shift in 2026 and beyond.
Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data
Previous Story

Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows
Next Story

Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows

Go toTop